Picture of Shield Therapeutics logo

STX — Shield Therapeutics News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Shield Therapeutics Says FY Total Revenue And Other Income Of $17.5 Mln

Feb 21 (Reuters) - Shield Therapeutics PLC  STXS.L :
    * SHIELD THERAPEUTICS  - UNAUDITED FULL YEAR TRADING UPDATE
    * SHIELD THERAPEUTICS PLC - FULL YEAR 2023 TOTAL REVENUE AND
OTHER
INCOME OF $17.5M COMPARED TO $6.2M IN 2022
    * SHIELD THERAPEUTICS PLC - FULL YEAR 2023 ACCRUFER® REVENUE
OF
$11.6M, APPROXIMATELY THREE TIMES MORE THAN PRIOR YEAR

Source text for Eikon:  ID:nRSU8985Da 
Further company coverage:  STXS.L 

 (Reuters.Briefs@thomsonreuters.com)

Recent news on Shield Therapeutics

See all news